Skip to main content

Day: September 22, 2020

Top-Line Results of Phase 2 SIGNAL Study in Huntington’s Disease Support Potential for Cognitive Benefit of Pepinemab

Key cognitive endpoints trending towards but did not reach statistical significance in early manifest population. Overall study does not meet pre-specified co-primary endpointsResults support continued development in Alzheimer’s disease and in mid-stage Huntington’s disease patients with greater cognitive deficitsCompany to host investor conference call today, September 22, at 8:30 a.m. EDTTo access the call and webcast, please click here.ROCHESTER, N.Y., Sept. 22, 2020 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced topline results from the early manifest treatment arm (Cohort B1, N=179) of the Phase 2 double-blind, placebo-controlled SIGNAL trial of its...

Continue reading

BridgeBio Pharma to Host Virtual R&D Day on September 29, 2020

PALO ALTO, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company focused on genetic diseases and cancers with clear genetic drivers, today announced that it will host its first R&D Day on Tuesday, September 29, at 8:30 am E.T.The virtual event will feature presentations from BridgeBio founder and CEO, Neil Kumar, Ph.D., senior scientists and physicians leading BridgeBio’s drug discovery and development programs, and top academic physicians and scientists from outside the company.The program will focus on BridgeBio’s drug engineering platform, its targeted oncology portfolio, and four highlighted programs with clinical data anticipated in the next 12-24 months – acoramidis (AG10, TTR stabilizer) for transthyretin amyloidosis, low-dose infigratinib (FGFR...

Continue reading

Art Angels Supports Restoration of Art Industry with Collection Sites COVID-19 Testing Services and Protocols

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) through its wholly-owned subsidiary, Collection Sites, LLC is working with Art Angels Gallery, Los Angeles, California to launch COVID-19 testing protocols to help safely return art exhibitions for artists and consumers. This event will feature world-renown artist Russell Young September 24th, 2020 in Beverly Hills, California.The COVID-19 testing and operating protocols have been developed by medical experts and QuestCap advisors, Dr. Glenn Copeland and Dr. Lawrence Steinman, and will help ensure the safety of employees, artists, and viewers. The testing consist of both digital temperature checks and rapid serology tests using...

Continue reading

Gold’n Futures enters into Letter of Intent with Argonaut Gold Inc.

TORONTO, Sept. 22, 2020 (GLOBE NEWSWIRE) — GOLD’N FUTURES MINERAL CORP. (CSE: FUTR) (FSE: G6M), (the “Company”), is pleased to announce that it has entered into a non-binding letter of intent with Argonaut Gold Inc. (“Argonaut”) to acquire up to a 90% interest in the Hercules – Elmhurst property (the “Property”) located 120 kilometers northeast of Thunder Bay, Ontario in the townships of Elmhurst and Rickaby, within the Thunder Bay North Mining District (the “LOI”).   The Property lies within an Archean greenstone belt that extends from the Longlac area in the east to Lake Nipigon in the west, a distance of some 130 kilometers. The property consists of 372 contiguous claim cells (6951 hectares).To date, the work completed on the Property forms an extensive database including reconnaissance grab samples; channel samples; a variety...

Continue reading

SYQH successfully logged into OTC

Boca Raton, FL, Sept. 22, 2020 (GLOBE NEWSWIRE) — SYQH acquired EVGI through reverse merger and acquisition.The assets of Liaoning Shuiyun Qinghe Rice Industry Co., LTD. (stock code: SYQH) will be loaded into the listed company in the form of reverse merger. The company will issue 1 billion shares and appoint Cui Weiming as the chairman and director and Chang Xu as the director.Founded in 2013, SYQH has been deeply engaged in the rice industry for more than a decade, and is a national enterprise integrating production and processing, chain sales and new retail. The company’s two brands, Shuiyun Qinghe and Shuiyun Daoxiang, have sold more than 100 series of products to more than 100 cities in China, and have deep cooperation with petrochina and Huilian. In addition to selling products, the company introduced food-related knowledge...

Continue reading

NewHold Investment Corp. Announces the Separate Trading of its Shares of Class A Common Stock and Warrants, Commencing on or about September 22, 2020

NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) — NewHold Investment Corp. (NASD: NHICU) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 17,250,000 units completed on July 30, 2020 (the “offering”) may elect to separately trade the shares of Class A common stock and warrants included in the units commencing on or about September 22, 2020. Any units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) under the symbol “NHICU”, and each of the shares of Class A common stock and the warrants will separately trade on the Nasdaq under the symbols “NHIC” and “NHICW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact...

Continue reading

U.S. Insurance Awards Name CorVel 2020 TPA Team of the Year

IRVINE, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — CorVel Corporation (NASDAQ: CRVL) was named Third Party Association Team of the Year at the Business Insurance U.S. Insurance Awards on September 10 for its innovative work with the State of Tennessee. The award honors teams of professionals that accomplish major achievements and demonstrate excellence in the commercial insurance and risk management sector.The State of Tennessee partnered with CorVel to increase the efficiency and cost-effectiveness of its program by leveraging CorVel’s integrated claims management services. Over the past two years, CorVel helped Tennessee implement a statewide return-to-work program, comprehensive pharmacy solutions, and an innovative intake process that includes 24/7 nurse triage and virtual care through telehealth. CorVel’s team effectively managed...

Continue reading

RESOLUTIONS of the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020

RESOLUTIONSof the Annual General Meeting of Shareholders of JSC „Olainfarm” to be held on September 22, 2020Report of the Board on results of operations in 2019.Resolution:To take notice of the Report of the Board of the JSC “Olainfarm” on results of operations in 2019.Voting results:  decision is taken with the required majority of votes.Report of the Council on results of operations in 2019.Resolution:To take notice of the Report of the Council of the JSC “Olainfarm” on results of operations in 2019.Voting results:  decision is taken with the required majority of votes.Approval of the JSC “Olainfarm”  Consolidated Annual Report for 2019.Resolution:To approve the Consolidated and Parent Company’s Annual Report of JSC „Olainfarm” for 2019 with profit in amount of EUR 22 239 000,00.Voting results:  decision is taken with the required majority...

Continue reading

Akciju sabiedrības “Olainfarm”, reģistrācijas numurs 40003007246, kārtējās 2020.gada 22.septembra akcionāru sapulces LĒMUMI

Akciju sabiedrības “Olainfarm”, reģistrācijas numurs 40003007246, kārtējās 2020.gada 22.septembra akcionāru sapulcesLĒMUMIValdes ziņojums par 2019. gada darbības rezultātiemLēmums:Pieņemt zināšanai akciju sabiedrības “Olainfarm” valdes ziņojumu par 2019.gada darbības rezultātiem.Balsošanas rezultāti: lēmums pieņemts ar nepieciešamo balsu vairākumu.Padomes ziņojums par 2019. gada darbības rezultātiemLēmums:Pieņemt zināšanai akciju sabiedrības “Olainfarm” padomes ziņojumu par 2019.gada darbības rezultātiem.Balsošanas rezultāti: lēmums pieņemts ar nepieciešamo balsu vairākumu.Akciju sabiedrības „Olainfarm” 2019. gada konsolidētā gada pārskata apstiprināšanaLēmums:Apstiprināt akciju sabiedrības „Olainfarm” 2019. gada konsolidēto un mātes sabiedrības gada pārskatu, ar peļņu 22 239 000,00 euro apmērā.Balsošanas rezultāti: lēmums pieņemts ar...

Continue reading

MediPharm Labs Enters Brazil – Latin America’s Largest Medical Cannabis Market in Partnership with XLR8 Brazil

BARRIE, Ontario, Sept. 22, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply premium, GMP-certified formulated cannabis oil to XLR8 BRAZIL (“XLR8”), a Rio de Janeiro based value-added distributor serving Brazil, Latin America’s largest medical cannabis market.Under the two-year agreement commencing from the time of product authorization, MediPharm Labs Inc. will provide a variety of cannabis concentrate formats for patient-ready formulated products that will be distributed by XLR8 to leading pharmacies and other authorized channels in Brazil. The initial product...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.